Peter Mousseau

FDA Filings

This page includes the latest FDA filings for Peter Mousseau. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.

FDA Registration(s)
Registration Number3003747162
FEI Number3003747162
NamePeter Mousseau
Owner & OperatorGenial Helix Ltd
Contact AddressUnit 62 CoWorkz Business Centre
Chester GB-FLN Flintshire CH1 4QL GB
Official Correspondent
  • Lawrence Crees
  • 44-01244-757155-x
US Agent
Registration Status1
Initial ImporterN
Registration Expiration2020-04-25
Registration Address83 Maple Avenue
Windsor, CT 06095 US
Establishment TypeManufacture Medical Device

FDA Filings

Device
Company
DeviceDate
Peter Mousseau [Genial Helix Ltd]
Solid Tumour Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Skin Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Product of Conception Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Lymphoma Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Lymphocyte Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Bone Marrow Growth Supplement2019-04-18
Peter Mousseau [Genial Helix Ltd]
Pre-Hypotonic Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Optimal Hypotonic Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Metaphase Arresting Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Erythrocyte Lysis Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Cytoclear2019-04-17
Peter Mousseau [Genial Helix Ltd]
Buffered Hypotonic Solution2019-04-17
Peter Mousseau [Genial Helix Ltd]
Anti-Clotting Reagent2019-04-17

Similar & Related FDA Registered Companies

Related Finance Registrations
U.S. Import Records [external site]
Import IDShipmentCargo DescriptionQuantity
2020060143486Yantian,China (Mainland) -> Oakland, CaliforniaRESISTANCE BANDS1 PCS
© 2025 FDA.report
This site is not affiliated with or endorsed by the FDA.